Ramiro G. Peru - Feb 7, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
Director
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Feb 7, 2024
Transactions value $
-$376,500
Form type
4
Date filed
2/9/2024, 04:22 PM
Previous filing
Aug 31, 2023
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Sale -$377K -753 -7.64% $500.00 9.11K Feb 7, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 3, 2023.
F2 This transaction was executed in multiple trades, each at the same price of $500.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected.